Multiple system atrophy-parkinsonism with slow progression and prolonged survival: A diagnostic catch

被引:90
作者
Petrovic, Igor N. [1 ,2 ,4 ]
Ling, Helen [1 ,2 ,3 ]
Asi, Yasmine [3 ]
Ahmed, Zeshan [3 ]
Kukkle, Prashanth L. [5 ]
Hazrati, Lili-Naz [5 ]
Lang, Anthony E. [5 ]
Revesz, Tamas [3 ]
Holton, Janice L. [3 ]
Lees, Andrew J. [1 ,2 ,3 ]
机构
[1] UCL Inst Neurol, Reta Lila Weston Inst Neurol Studies, London WC1N 1PJ, England
[2] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England
[3] Univ Belgrade, Neurol Clin, CCS, Belgrade, Serbia
[4] UCL Inst Neurol, Dept Mol Neurosci, Queen Sq Brain Bank, London WC1N 1PJ, England
[5] Univ Toronto, Toronto Western Hosp, Toronto, ON M5T 2S8, Canada
关键词
multiple system atrophy; parkinsonism; MSA-P; autonomic dysfunction; visual hallucination; slow progression; ATYPICAL PARKINSONISM; VISUAL HALLUCINATIONS; SUPRANUCLEAR PALSY; CLINICAL-FEATURES; DISEASE; STIMULATION; PROGNOSIS; LEVODOPA; CRITERIA; FALLS;
D O I
10.1002/mds.25115
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Multiple system atrophy (MSA) is a neurodegenerative disease leading to severe physical impairment, with a disease duration from onset to death of 69 years. Methods: The clinical and neuropathological features of 4 MSA cases with disease duration of 15 years or more were analyzed. Results: All patients presented with parkinsonism and had a mean latency of 11 years before the development of dysautonomia. Mean duration from onset of first symptoms to anterocollis, inspiratory stridor, and dysphagia was 9 years. Despite the limited levodopa response, all patients developed levodopa-induced dyskinesia. Conclusions: Late appearance of dysautonomia is a favorable prognostic factor in MSA-P. Greater awareness of this uncommon benign subgroup of MSA will improve diagnostic accuracy and help to more accurately inform treatment options. (c) 2012 Movement Disorder Society
引用
收藏
页码:1184 / 1188
页数:5
相关论文
共 33 条
[1]   Clinical phenotype of subjects with Parkinson's disease and orthostatic hypotension: Autonomic symptom and demographic comparison [J].
Allcock, Liesl M. ;
Kenny, Rose Anne ;
Burn, David J. .
MOVEMENT DISORDERS, 2006, 21 (11) :1851-1855
[2]   Survival of patients with pathologically proven multiple system atrophy: A meta-analysis [J].
BenShlomo, Y ;
Wenning, GK ;
Tison, F ;
Quinn, NP .
NEUROLOGY, 1997, 48 (02) :384-393
[3]  
Boesch SM, 2002, J NEUROL NEUROSUR PS, V72, P300, DOI 10.1136/jnnp.72.3.300
[4]   Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry [J].
Braak, Heiko ;
Alafuzoff, Irina ;
Arzberger, Thomas ;
Kretzschmar, Hans ;
Del Tredici, Kelly .
ACTA NEUROPATHOLOGICA, 2006, 112 (04) :389-404
[5]   Longitudinal study of the motor response to levodopa in Parkinson's disease [J].
Clissold, Benjamin G. ;
McColl, Craig D. ;
Reardon, Katrina R. ;
Shiff, Mark ;
Kempster, Peter A. .
MOVEMENT DISORDERS, 2006, 21 (12) :2116-2121
[6]  
DSM-IV, 1995, DSM 4 DIAGN STAT MAN
[7]   Clinical diagnostic criteria for dementia associated with Parkinson's disease [J].
Emre, Murat ;
Aarsland, Dag ;
Brown, Richard ;
Bum, David J. ;
Duyckaerts, Charles ;
Mizuno, Yoshikino ;
Broe, Gerald Anthony ;
Cummings, Jeffrey ;
Dickson, Dennis W. ;
Gauthier, Serge ;
Goldman, Jennifer ;
Goetz, Christopher ;
Korczyn, Amos ;
Lees, Andrew ;
Levy, Richard ;
Litvan, Irene ;
McKeith, Ian ;
Olanow, Warren ;
Poewe, Werner ;
Quinn, Niall ;
Sampaio, Christina ;
Tolosa, Eduardo ;
Dubois, Bruno .
MOVEMENT DISORDERS, 2007, 22 (12) :1689-1707
[8]   Second consensus statement on the diagnosis of multiple system atrophy [J].
Gilman, S. ;
Wenning, G. K. ;
Low, P. A. ;
Brooks, D. J. ;
Mathias, C. J. ;
Trojanowski, J. Q. ;
Wood, N. W. ;
Colosimo, C. ;
Duerr, A. ;
Fowler, C. J. ;
Kaufmann, H. ;
Klockgether, T. ;
Lees, A. ;
Poewe, W. ;
Quinn, N. ;
Revesz, T. ;
Robertson, D. ;
Sandroni, P. ;
Seppi, K. ;
Vidailhet, M. .
NEUROLOGY, 2008, 71 (09) :670-676
[9]   Cell survival and clinical outcome following intrastriatal transplantation in Parkinson disease [J].
Hagell, P ;
Brundin, P .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2001, 60 (08) :741-752
[10]   Pallidal stimulation reduces treatment-induced dyskinesias in "minimal-change" multiple system atrophy [J].
Huang, Y ;
Garrick, R ;
Cook, R ;
O'Sullivan, D ;
Morris, J ;
Halliday, GM .
MOVEMENT DISORDERS, 2005, 20 (08) :1042-1047